For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.
Scope of the Report:
This report focuses on the BCG Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The global average gross margin of BCG Vaccine is in an decreasing trend, from 71.59% in 2012 to 69.46% in 2017. With the situation of global economy, gross margin will be in decreasing trend in the following five years.
The type of BCG Vaccine includes Immune BCG and Therapy BCG. The proportion of Therapy BCG in 2016 is about 92.73%.
BCG Vaccine is widely used in Hospitals and Clinics. The most proportion of BCG Vaccine is sold in Hospitals and the market share in 2016 is about 74.14%, and the Hospitals have upstream trend.
North America is the largest supplier of BCG Vaccine, with a production market share nearly 32.58% in 2016. Europe is the second largest supplier of BCG Vaccine Media, enjoying production market share nearly 29.74% in 2016.
North America region is the largest consumption of BCG Vaccine, with a sales revenue market share nearly 36.40% in 2016. Europe is the second largest consumer of BCG Vaccine, enjoying sales revenue market share about 32.43% in 2016.
Market competition is not intense. Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India, Intervax, GSBPL are the leaders of the industry, and they have been formed in the monopoly position in the industry.
The worldwide market for BCG Vaccine is expected to grow at a CAGR of roughly 5.5% over the next five years, will reach 410 million US$ in 2023, from 300 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Sanofi Pasteur
- Japan BCG Lab
- China National Biotec
- Serum Institute of India
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Immune BCG
- Therapy BCG
Market Segment by Applications, can be divided into
There are 15 Chapters to deeply display the global BCG Vaccine market.
Chapter 1, to describe BCG Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of BCG Vaccine, with sales, revenue, and price of BCG Vaccine, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of BCG Vaccine, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, BCG Vaccine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe BCG Vaccine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source